091 Multi-disciplinary team assessment of high risk patients with severe aortic valve stenosis leads to better than predicted survival, earlier tracheal extubation and shorter intensive care stay

Introduction Treatment of high risk patients with severe aortic valve stenosis has been revolutionised by Transcatheter Aortic Valve Implantation (TAVI). We hypothesise that multi-disciplinary team (MDT) assessment by cardiologists, cardiothoracic surgeons and anaesthetists facilitates appropriate case selection and achieves better than predicted outcomes in this high risk group. Methods All patients (n=111) referred to the MDT for TAVI were prospectively enrolled. Baseline demographics and outcomes were recorded. Results are median (IQR) unless stated. Results Patients (n=25) awaiting treatment/final MDT decision were excluded. Twenty patients were treated by TAVI (seven transfemoral, 13 transapical), 27 by conventional surgical AVR (csAVR), nine with balloon aortic valvuloplasty (BAV) and 30 medically. There were no differences in baseline characteristics (except for an excess of prior CABG surgery in the TAVI group vs csAVR (16/20 vs 3/27; p Thirty-day mortalities were: TAVI: 0/19; csAVR: 0/27; BAV: 1/9; medical: 8/30 (abstract 091 figure 1). Adjusting for ES, the observed/expected 30 day mortality indices were: TAVI: 0; csAVR: 0; BAV: 0.37; medical: 1.31. Patients receiving valve replacement (TAVI and csAVR) had lower 30-day mortality than those receiving palliative treatment (BAV and medical): 0% vs 23.1%, p TAVI patients had shorter intensive care unit (ICU) stays than csAVR patients: 22.0 (9.9–41.3) h vs 36.6 (23.3–169.2) h, p=0.03 and shorter durations of tracheal intubation: 2.1 (1.9–5.8) h vs 11.9 (8.6–20.1) h, p Conclusion MDT assessment of high risk patients with severe aortic valve stenosis combined with multi-modality treatment options results in lower than predicted mortality. Patients selected for TAVI have shorter ICU stays than patients selected for csAVR despite equivalent co-morbidities.